| P50 | author | Graham R. V. Hughes | Q73300356 |
| P2093 | author name string | M J Cuadrado | |
| P2860 | cites work | Thrombocytopenia in the antiphospholipid syndrome | Q73306638 |
| | Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease | Q73352597 |
| | Antiphospholipid syndrome and renal artery stenosis | Q73505498 |
| | A reversible bilateral renal artery stenosis in association with antiphospholipid syndrome | Q73540179 |
| | Migraine and stroke in young women | Q73822136 |
| | Resolution of vegetations with anticoagulation after myocardial infarction in primary antiphospholipid syndrome | Q73844714 |
| | Widespread cutaneous necrosis occurring in association with the antiphospholipid syndrome: a report of two cases | Q73883217 |
| | Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction | Q73965948 |
| | Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients | Q74284472 |
| | Systemic lupus erythematosus with myocardial dysfunction due to microvasculopathy | Q74300511 |
| | Primary antiphospholipid antibody syndrome and retinal occlusive vasculopathy | Q74424038 |
| | Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study | Q74575122 |
| | Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS? | Q77228517 |
| | Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I | Q77296598 |
| | A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus | Q77352546 |
| | Echocardiographic evaluation of patients with primary antiphospholipid syndrome | Q77375392 |
| | Increased endothelial cell expression of alpha3beta1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome | Q78248067 |
| | CEREBRO-VASCULAR LESIONS AND LIVEDO RETICULARIS | Q28201845 |
| | Sneddon syndrome with or without antiphospholipid antibodies. A comparative study in 46 patients | Q33329596 |
| | Splenectomy for refractory thrombocytopenia in the antiphospholipid syndrome | Q33330250 |
| | Autoimmune hemolytic anemia in patients with systemic lupus erythematosus | Q33331802 |
| | Risk factors for central nervous system involvement in systemic lupus erythematosus | Q33332006 |
| | Frequency, potential risk and therapeutic intervention in end-stage renal disease patients with antiphospholipid antibody syndrome: a multicenter study | Q33332343 |
| | The mystery of Sneddon syndrome: relationship with antiphospholipid syndrome and systemic lupus erythematosus | Q33333901 |
| | Anticardiolipin antibodies, haemolytic anaemia and thrombocytopenia in systemic lupus erythematosus | Q33369204 |
| | Antiphospholipid antibodies, prethrombotic states, and stroke | Q33394670 |
| | Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases | Q33408807 |
| | Clinical and immunologic features of livedo reticularis in lupus: a case-control study | Q33437881 |
| | Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients | Q33438663 |
| | The spectrum of livedo reticularis and anticardiolipin antibodies. | Q33444402 |
| | Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes | Q33448386 |
| | Anticardiolipin antibodies, livedo reticularis, and major cerebrovascular and renal disease in systemic lupus erythematosus | Q33450672 |
| | The Prosser-White oration 1983. Connective tissue disease and the skin | Q33478362 |
| | Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome | Q33488745 |
| | Renal transplantation in anticardiolipin antibody-positive lupus erythematosus patients | Q33493550 |
| | Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control study | Q33494721 |
| | Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome | Q33495531 |
| | The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases | Q33498243 |
| | Enrichment of antibodies against phospholipids in circulating immune complexes (CIC) in the anti-phospholipid syndrome (APLS). | Q33498920 |
| | Antibodies to thromboplastin in systemic lupus erythematosus: isotype distribution and clinical significance in a series of 92 patients | Q33499417 |
| | Antiphospholipid syndrome and the skin | Q33499667 |
| | Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome | Q33500479 |
| | A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis | Q33500954 |
| | Autoimmune thrombocytopenia in primary antiphospholipid syndrome and systemic lupus erythematosus: the response to splenectomy | Q33503507 |
| | Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome | Q33561648 |
| | Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus | Q33562546 |
| | Anticardiolipin antibodies and renovascular hypertension | Q33584068 |
| | Pulmonary hypertension and the antiphospholipid syndrome | Q70903736 |
| | Affinity-purified cardiolipin-binding antibodies show heterogeneity in their binding to oxidized low-density lipoprotein | Q71068052 |
| | Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings | Q71115742 |
| | Antiphospholipids in hemodialysis patients: relationship between lupus anticoagulant and thrombosis | Q71517613 |
| | Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis | Q71614846 |
| | Antiphospholipid antibodies and retinal vascular disease | Q71683350 |
| | Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythmatosus patients: a controlled prospective study | Q71691168 |
| | Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus | Q71775354 |
| | Heart valve disease in systemic lupus erythematosus. Role of antiphospholipid antibodies | Q71992278 |
| | Anticardiolipin antisera from lupus patients with seizures reduce a GABA receptor-mediated chloride current in snail neurons | Q72350707 |
| | Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men | Q72369034 |
| | Renal vein thrombosis caused by primary antiphospholipid syndrome | Q72424634 |
| | Ocular vaso-occlusive disease in primary antiphospholipid syndrome | Q72560771 |
| | Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients | Q72764443 |
| | Alternating hemichorea in primary antiphospholipid syndrome: evidence for contralateral striatal hypermetabolism | Q72829611 |
| | Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study | Q73106702 |
| | Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): clinical features, pathogenesis, review of the literature and proposed ophthalmological criteria for APS diagnosis | Q33651777 |
| | Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature | Q33835528 |
| | Recent advances in antiphospholipid antibody-related valvulopathies | Q34021232 |
| | Speculations on APS in the coming millennium | Q34021338 |
| | Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature | Q36866914 |
| | Case-control study of migraine and risk of ischaemic stroke in young women | Q36902964 |
| | Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception | Q37398612 |
| | The oxidation hypothesis of atherosclerosis | Q40625668 |
| | Multiple subungual splinter hemorrhages in the antiphospholipid syndrome: a report of five cases and review of the literature | Q40628382 |
| | The natural course of cerebral lesions in Sneddon syndrome | Q41327499 |
| | Widespread cutaneous necrosis and antiphospholipid antibodies: two episodes related to surgical manipulation and urinary tract infection | Q41467176 |
| | Outcome of renal transplantation in systemic lupus erythematosus | Q41587448 |
| | Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment | Q41587455 |
| | Cognition and mood in systemic lupus erythematosus. Evaluation and pathogenesis | Q41590479 |
| | A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus | Q41647250 |
| | Reversible chorea in primary antiphospholipid syndrome | Q41695143 |
| | Intracardiac thrombus in antiphospholipid antibody syndrome | Q41760600 |
| | Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus | Q41837002 |
| | Reversible dementia and chorea in a young woman with the lupus anticoagulant | Q41930792 |
| | Unfading acral microlivedo. A discrete marker of thrombotic skin disease associated with antiphospholipid antibody syndrome | Q42012453 |
| | Autoimmune aberration in sudden sensorineural hearing loss: association with anti-cardiolipin antibodies | Q43408615 |
| | Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease | Q44114961 |
| | Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). | Q44583525 |
| | Valvular heart disease in the primary antiphospholipid syndrome | Q46730841 |
| | Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. | Q48144813 |
| | Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes | Q48245672 |
| | Increased immunoglobulin binding to cerebral endothelium in patients with antiphospholipid antibodies | Q48259097 |
| | Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis | Q48394757 |
| | Antiphospholipid antibodies in cerebral ischemia | Q48709466 |
| | Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy. | Q50944728 |
| | Association between migraine and stroke in a large-scale epidemiological study of the United States. | Q50961206 |
| | Prevalence and clinical significance of antiphospholipid antibodies in heart valve disease: a case-control study. | Q51006300 |
| | History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young. | Q51026135 |
| | Pulmonary veno-occlusive disease, antiphospholipid antibody and pulmonary hypertension in an adolescent. | Q53928706 |
| | Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus | Q57602230 |
| | Anticardiolipin Antibodies and Physical Disability in the Elderly | Q57606069 |
| | Value of immunologic testing in stroke patients. A prospective multicenter study | Q60429393 |
| | Allograft membranous glomerulonephritis and renal-vein thrombosis in a patient with a lupus anticoagulant factor | Q67235729 |
| | Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies | Q67511161 |
| | High Prevalence of Significant Heart Valve Lesions in Patients with the 'Primary' Antiphospholipid Syndrome | Q67911740 |
| | Cardiac involvement in patients with primary antiphospholipid syndrome | Q67977013 |
| | Cardiovascular disease in systemic lupus erythematosus. A study of 75 patients form a defined population | Q68035493 |
| | Vasculitis in the antiphospholipid syndrome. A cause of ischemia responding to corticosteroids | Q68109852 |
| | Increased IgM-anticardiolipin antibodies in patients with restenosis after percutaneous transluminal coronary angioplasty | Q68125227 |
| | Antiphospholipid antibodies and cerebral ischemia in young people | Q68347645 |
| | Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events | Q69874910 |
| | Anticardiolipin antibodies and occlusion of coronary artery bypass grafts | Q69908023 |
| | Cerebrovascular lesions and livedo reticularis (Sneddon's syndrome)--a progressive cerebrovascular disorder? | Q70062019 |
| | Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. The Antiphospholipid Antibodies in Stroke Study (APASS) Group | Q70514603 |
| | Sneddon's syndrome and antiphospholipid antibodies | Q70740286 |
| | The presence of antiphospholipid antibodies in acute myocardial infarction | Q70803300 |
| P433 | issue | 3 | |
| P304 | page(s) | 507-24, v | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | Rheumatic Diseases Clinics of North America | Q7320483 |
| P1476 | title | Hughes (antiphospholipid) syndrome. Clinical features | |
| P478 | volume | 27 | |